Incraft®装置腹主动脉瘤腔内修复术多中心中期结果
初手术技术成功率97.4%,辅助后达100%;1、2、3年临床成功率分别为97.3%、92.8%、89.4%,提示该装置在真实世界条件下可靠。
要点
- 初手术技术成功率97.4%,辅助后达100%,无术中死亡或转开放。
- 1、2、3年临床成功率分别为97.3%、92.8%、89.4%。
- 3例(3.9%)瘤囊增大>5 mm,均伴II型内漏,2例接受栓塞。
核心结论
- Incraft®装置行EVAR在真实世界条件下(不限于复杂髂动脉解剖)可视为可靠选择。
主要发现
- 初手术技术成功率97.4%,辅助后技术成功率100%;术中最终造影可见小II型内漏19例(24.7%)。
- 无术中AAA破裂死亡、无原发性转开放或转主髂单侧支架;发生2例需杂交技术修复的并发症;30天内无死亡。
- 支架腿闭塞2例(2.6%),分别于植入后6和14个月发生,经腔内再通失败后行股-股PTFE旁路。
- 3例(3.9%)瘤囊较1个月CT增大>5 mm,均伴II型内漏,其中2例接受栓塞治疗。
临床怎么用
- 在真实世界条件下,Incraft®装置可用于肾下AAA的EVAR,不限于复杂髂动脉解剖。
- 术后需监测内漏(尤其II型)及瘤囊增大,支架腿闭塞风险需长期随访关注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Durability after endovascular aortic aneurysm repair (EVAR) is considered an ongoing topic of investigation and was always a point of concern with smaller profile devices. Recently released five-year clinical trial results using the Incraft® ultralow profile device are encouraging. However, additional real-life experience will need to assist these initial findings. Herein, we investigated the outcomes after EVAR, in real world practice using the Incraft® endograft (EG). MATERIAL AND METHODS: Seventy-seven patients with infrarenal abdominal aortic aneurysms (AAA) ≥50 mm in diameter treated with the Incraft® device in three vascular centers were enrolled from November 2015 to July 2018. Follow-up was completed in August 2020. Selection of EVAR using the Incraft® device was individualized according to aorto-iliac morphologic features, comorbidities, history of previous abdominal surgery and preference of the patient. At the early phase of the study, we specifically opted for preferential use of this low profile EG mainly in cases of small and tortuous iliac vessels (more challenging access routes). At later stages, it was used according to surgeon preference and not specifically in complex anatomies (real-world conditions). End-points included technical success, perioperative complications, 30-day survival, endoleg patency, presence of endoleaks, sac enlargement >5 mm and clinical success. RESULTS: The primary technical success rate was 97.4% before the addition of an aortic cuff and iliac extension for a type Ia and type Ib endoleak respectively, and the repair of a maldeployment iliac component (primary-assisted and secondary technical success, 100%). Intraoperative small type II endoleaks (visible in final angiogram) were noted in 19 patients (24.7%). There were no intraoperative deaths from AAA rupture, primary conversions or conversions to aortounilateral grafts. Two complications occurred, necessitating hybrid techniques for repair (replaced of a dislodged endoleg and distal external iliac artery hemostasis). No deaths were reported within 30 days. Occlusion of an endoleg, was observed in two patients, 6 and 14 months respectively after implantation (2.6%), and were treated by femoral-femoral PTFE bypass after unsuccessful endovascular recanalization. The latter required open conversion, 3 mo later, to repair compromised flow to the inflow iliac axis. Three patients (3.9%) experienced sac enlargement >5 mm in diameter compared with the 1-month CT scan. All of these had type II endoleaks and two received embolization procedures. Eleven patients died from causes unrelated to AAA repair. Clinical success was 97.3%, 92.8% and 89.4% through 1, 2 and 3 years respectively. CONCLUSIONS: EVAR with the Incraft® device might be considered a reliable option in real-world conditions and not specifically only in complex iliac anatomies.
引用
- Georgiadis GS, Chatzigakis PK, Kouvelos G, et al. Multicenter Mid-term Results After Endovascular Aortic Aneurysm Repair with the Incraft® Device. Ann Vasc Surg. 2020. PMID: 32946999. doi:10.1016/j.avsg.2020.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。